Type 2 Diabetes Mellitus
Also known as: Diabete Type 2 / Diabetes Mellitus II / Type Two Diabetes Mellitus / Type 2 Diabetes Mellitus (T2DM) / T2DM / Type 2 Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus,Type 2 / Diabetes, Type II / Diabetes mellitus: [adult onset] or [noninsulin dependent] / Non-insulin-dependent diabetes mellitus / Diabetes mellitus type 2 (disorder) / Diabetes mellitus: [adult onset, with no mention of complication] or [maturity onset] or [non-insulin dependent] / NIDDM / Diabetes Mellitus, Type 2 / Diabetes mellitus non-insulin-dependent / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset
Drug | Drug Name | Drug Description |
---|---|---|
DB00284 | Acarbose | An alpha-glucosidase inhibitor used in adjunctly with diet and exercise for the management of glycemic control in patients with type 2 diabetes mellitus. |
DB09043 | Albiglutide | A GLP-1 agonist used to manage type 2 diabetes mellitus. |
DB06203 | Alogliptin | A dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat hyperglycemia in patients with type 2 diabetes mellitus. |
DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
DB12236 | Bexagliflozin | A sodium-glucose co-transporter 2 inhibitor used to improve glycemic control in patients with type 2 diabetes mellitus. |
DB01200 | Bromocriptine | A dopamine D2 receptor agonist used for the treatment of galactorrhea due to hyperprolactinemia and other prolactin-related conditions, as well as in early Parkinsonian Syndrome. |
DB08907 | Canagliflozin | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. |
DB00672 | Chlorpropamide | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. |
DB00930 | Colesevelam | A bile acid sequestrant used to lower LDL-C in adults with hyperlipidemia and pediatric patients with heterozygous familial hypercholesterolemia, and to improve glycemic control in type 2 diabetes. |
DB06292 | Dapagliflozin | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. |
DB09045 | Dulaglutide | A GLP-1 agonist used to manage type 2 diabetes mellitus. |
DB09038 | Empagliflozin | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. |
DB11827 | Ertugliflozin | An SGLT2 inhibitor used to treat type 2 diabetes mellitus alone or in combination with other antidiabetic drugs. |
DB01276 | Exenatide | A GLP-1 agonist used in the management of type 2 diabetes mellitus. |
DB16165 | Finerenone | A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. |
DB12412 | Gemigliptin | A dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus. |
DB01120 | Gliclazide | A sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus. |
DB00222 | Glimepiride | A sulfonylurea drug used to treat type 2 diabetes mellitus. |
DB01067 | Glipizide | A sulfonylurea medication used in Type 2 Diabetes to sensitize pancreatic beta cells and stimulate insulin release. |
DB01251 | Gliquidone | A sulfonylurea drug used in the management of diabetes mellitus type 2. |
DB00040 | Glucagon | A form of recombinant glucagon used to treat hypoglycemia in diabetes mellitus and as a part of gastrointestinal imaging procedures. |
DB01016 | Glyburide | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. |
DB09564 | Insulin degludec | A long acting insulin used to treat hyperglycemia caused by type 1 and 2 diabetes mellitus. |
DB01307 | Insulin detemir | A long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. |
DB00047 | Insulin glargine | A modified form of long-acting or basal insulin used to control hyperglycemia in diabetes mellitus. |
DB08882 | Linagliptin | A dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus. |
DB00166 | Lipoic acid | For nutritional supplementation, also for treating dietary shortage or imbalance. |
DB06655 | Liraglutide | A GLP-1 analog used in the management of type 2 diabetes mellitus and prevention of cardiovascular complications associated with diabetes. |
DB09265 | Lixisenatide | A GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. |
DB00678 | Losartan | An angiotensin receptor blocker used to treat hypertension and diabetic nephropathy, and is used to reduce the risk of stroke. |
DB12214 | Luseogliflozin | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. |
DB00331 | Metformin | A biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS). |
DB00491 | Miglitol | An oral alpha-glucosidase inhibitor used to improve glycemic control by delaying the digestion of carbohydrates. |
DB01252 | Mitiglinide | For the treatment of type 2 diabetes. |
DB00731 | Nateglinide | A meglitinide used to treat non insulin dependent diabetes mellitus. |
DB01132 | Pioglitazone | A thiazolidinedione used adjunctively with diet and exercise to normalize glycemic levels in adults with type 2 diabetes mellitus. |
DB01278 | Pramlintide | An amylin analog used for the management of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy. |
DB00912 | Repaglinide | A antihyperglycemic used to improve glycemic control in diabetes. |
DB00412 | Rosiglitazone | A thiazolidinedione indicated as an adjunct to diet and exercise to maintain glycemic control in type 2 diabetes. |
DB06335 | Saxagliptin | An DPP-4 inhibitor used for the management of type 2 diabetes mellitus. |
DB13928 | Semaglutide | A glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus. |
DB00641 | Simvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular events including myocardial infarction and stroke. |
DB01261 | Sitagliptin | An oral dipeptidyl peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus. |
DB12713 | Sotagliflozin | An orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus. |
DB11950 | Teneligliptin | Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus. |
DB15171 | Tirzepatide | A dual GIP and GLP-1 receptor agonist used for the treatment of type II diabetes in adults as an adjunct to diet and exercise. |
DB00839 | Tolazamide | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. |
DB01124 | Tolbutamide | A sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus. |
DB00273 | Topiramate | An anticonvulsant drug used in the control of epilepsy and in the prophylaxis and treatment of migraines. |
DB15323 | Trelagliptin | A dipeptidyl peptidase-4 inhibitor indicated in the control of diabetes mellitus. |
DB00177 | Valsartan | An angiotensin-receptor blocker used to manage hypertension alone or in combination with other antihypertensive agents and to manage heart failure in patients who are intolerant to ACE inhibitors. |
DB04876 | Vildagliptin | A once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. |
DB04878 | Voglibose | An alpha-glucosidase inhibitor indicated in the management of postprandial blood glucose in patients with type II diabetes. |